Skip to main content
. Author manuscript; available in PMC: 2019 Oct 11.
Published in final edited form as: JAMA Cardiol. 2017 Apr 1;2(4):451–452. doi: 10.1001/jamacardio.2016.5162

Figure 2:

Figure 2:

Statin Prescription Rate for Patients With Low-Density Lipoprotein Levels of 190 mg/dL or Greater, by Age Group

Patients with low-density lipoprotein (LDL-C) levels of 190 mg/dL or greater (to convert LDL-C values to millimoles per liter, multiply by 0.0259) were analyzed on the basis of whether a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor or statin was prescribed and were then stratified by age group and sex. Younger patients were less likely to be prescribed a statin.